(NHI) National Health Investors - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US63633D1046

NHI: Senior Housing, Nursing Facilities, Hospitals, Retirement Communities

National Health Investors, Inc. (NYSE:NHI), established in 1991, stands as a prominent real estate investment trust (REIT) focused on the healthcare sector. NHIs strategy revolves around acquiring and financing properties that cater to senior housing and medical facilities, leveraging a diverse approach to mitigate risks. Their investment tactics include sale-leaseback transactions, joint ventures, and providing mortgage and mezzanine financing, which not only diversifies their portfolio but also ensures a steady income stream through rents.

NHIs portfolio is a testament to their strategic diversification, encompassing a range of facilities such as independent living communities, assisted living and memory care units, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. This diversification is crucial as it spreads investment risk across different types of healthcare properties, ensuring stability even when certain sectors experience fluctuations. The aging population in the U.S. underscores a growing demand for such facilities, positioning NHI favorably in a growth-oriented market.

From a financial standpoint, NHI boasts a market capitalization of approximately $3.1 billion, reflecting its substantial presence in the REIT sector. The current P/E ratio of 23.63 indicates that investors are valuing the company based on its earnings potential, while the forward P/E of 12.84 suggests anticipation of future growth. The price-to-book ratio of 2.54 highlights that investors are willing to pay a premium over the book value, likely due to confidence in NHIs management and growth prospects. These metrics, coupled with the companys diversified portfolio, make NHI an attractive consideration for investors seeking exposure to the healthcare real estate market.

Additional Sources for NHI Stock

NHI Stock Overview

Market Cap in USD 3,413m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 1991-10-09

NHI Stock Ratings

Growth 5y 61.0%
Fundamental 32.1%
Dividend 42.1%
Rel. Strength 13.3
Analysts 3.88/5
Fair Price Momentum 76.49 USD
Fair Price DCF 101.45 USD

NHI Dividends

Dividend Yield 12m 4.98%
Yield on Cost 5y 11.36%
Annual Growth 5y -3.99%
Payout Consistency 93.8%

NHI Growth Ratios

Growth Correlation 3m 81%
Growth Correlation 12m 45.8%
Growth Correlation 5y 55%
CAGR 5y 18.41%
CAGR/Max DD 5y 0.58
Sharpe Ratio 12m 1.77
Alpha 18.67
Beta 1.116
Volatility 23.08%
Current Volume 303.8k
Average Volume 20d 241.7k
What is the price of NHI stocks?
As of April 03, 2025, the stock is trading at USD 73.77 with a total of 303,835 shares traded.
Over the past week, the price has changed by +0.74%, over one month by +1.81%, over three months by +9.20% and over the past year by +28.48%.
Is National Health Investors a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, National Health Investors is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.14 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NHI as of April 2025 is 76.49. This means that NHI is currently overvalued and has a potential downside of 3.69%.
Is NHI a buy, sell or hold?
National Health Investors has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy NHI.
  • Strong Buy: 3
  • Buy: 1
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecast for NHI stock price target?
According to ValueRays Forecast Model, NHI National Health Investors will be worth about 85 in April 2026. The stock is currently trading at 73.77. This means that the stock has a potential upside of +15.17%.
Issuer Forecast Upside
Wallstreet Target Price 82.1 11.3%
Analysts Target Price 79.6 7.9%
ValueRay Target Price 85 15.2%